In addition, oral administration of HY7801 improves vulvovaginal candidiasis by inhibiting the survival of Candida albicans and down-regulating TNF-α, COX-2, iNOS, and IL-1β levels [42]. This evidence concerns the gene IL1B and vulvovaginal candidiasis.